Advertisement

The association between RASSF1 gene polymorphisms and lung cancer susceptibility among people in Hubei Province of China

  • Geqiong Xiao (肖葛琼)
  • Tao Zhang (张 涛)
  • Jie Yao (姚 杰)
  • Jinghua Ren (任精华)
  • Wenmiao Cao (曹文淼)
  • Gang Wu (伍 钢)
Article

Summary

The relationship between Ala/Ser polymorphism in 133 codon of exon 3 region of the RASSF1 gene and genetic susceptibility of lung cancer in Hubei province Han population was investigated by a case-control study. Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) technique was adopted to analyze the polymorphism of codon 133 of exon 3 in the RASSF1 gene of 100 pathologically diagnosed lung cancer patients, and 100 healthy controls. The relationship between different genotypes and the susceptibility of lung cancer was analyzed. Among 200 blood samples from Han people in Hubei Province, including 100 from lung cancer patients and 100 from healthy controls, the frequencies of Ala/Ala, Ala/Ser, Ser/Ser genotype of the RASSF1 in lung cancer patients were 83%, 16%, 1%, and those in healthy controls was 93%, 7%, 0% respectively, with the difference being statistically significant between two groups (P<0.05). The individuals with Ala/Ser genotype had higher risk of suffering from lung cancer, with an OR of 2.341, and 95% CI of 1.009–6.393 respectively. It was concluded that RASSF1Ala133Ser was a susceptible genetic factor of lung cancer. Ala/Ser genotype increased the risk of lung cancer.

Key words

lung cancer the RASSF1 gene polymorphism genetic susceptibility fragment length 

References

  1. 1.
    Blot WJ, McLaughlin JK. Passive smoking and lung cancer risk: What is the study now? J Natl Cancer Inst, 1998,90(19):1416–1417PubMedCrossRefGoogle Scholar
  2. 2.
    Li DR, Zhou QH. Advances in studies on genetic susceptibility of lung cancer. Chin Lung Cancer (Chinese), 2003,6(2):158–162Google Scholar
  3. 3.
    Dammann R, Li C, Yoon JH, et al. Epigenetic inactivation of a RAS association domain family protein from the lung tumor suppressor locus 3p21.3. Nat Genet, 2000,25(3): 315–319PubMedCrossRefGoogle Scholar
  4. 4.
    Lerman MI, Minna JD. The 630kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. Cancer Res, 2000,60(21):6116–6133PubMedGoogle Scholar
  5. 5.
    Burbee DG, Forgacs E, Zochbauer-Muller S, et al. Epigenetic inactivation of RASSF1 A in lung and breast cancer and malignant phenotype suppression. J Natl Cancer Inst, 2001,93(9):691–699PubMedCrossRefGoogle Scholar
  6. 6.
    Yu MY, Tong JH, Chan PK, et al. Hypermethylation of the tumor suppressor gene RASSF1A and frequent concomitant loss of heterozygosity at 3p21 in cervical cancers. Int J Cancer, 2003,105(2):204–209PubMedCrossRefGoogle Scholar
  7. 7.
    Tommasi S, Dammann R. RASSF3 and NORE1: identification and cloning of two human homologues of the putative tumor suppressor gene RASSF1. Oncogene, 2002,21(17):2713–2720PubMedCrossRefGoogle Scholar
  8. 8.
    Hirotaka K, Hiroko H. Single nucleotide polymorphism at codon 133 of the RASSF1 gene is preferentially associated with human lung adenocarcinoma risk. Cancer Letters, 2006,238:128–134CrossRefGoogle Scholar
  9. 9.
    Endoh H, Yatabe Y, Shimizu S, et al. RASSFIA gene inactivation in non-small cell lung cancer and its clinical implication. Int J Cancer, 2003,106(1):45–51PubMedCrossRefGoogle Scholar
  10. 10.
    Kim DH, Kim JS, Park JH, et al. Relationship of Ras association domain family 1 methylation and K-Ras mutation in primary non-small cell lung cancer. Cancer Res, 2003,63:6206–6211PubMedGoogle Scholar
  11. 11.
    Ortiz-Vega S, Khokhlatchev A, Nedwidek M, et al. The putative tumor suppressor RASSFIA homodimerizes and heterodimerizes with the Ras-GTP binding protein NoreI. Oncogene, 2002,2l(9):l381–1390Google Scholar
  12. 12.
    Khokhlatchev A, Rabizadeh S, Xavier R, et al. Identification of a novel Ras-regulated proapoptotic pathway. Cur Biol, 2002,12(4):253–265CrossRefGoogle Scholar
  13. 13.
    Song MS, Song SJ, Ayad NG, et al. The tumor suppressor RASSF1A regulates mitosis by inhibiting the APC-Cdc20 complex. Nat Cell Biol, 2004,6(2):129–137PubMedCrossRefGoogle Scholar
  14. 14.
    Rong R, Jin W, Zhang J, et al. Tumor suppressor RASSF1A is a microtubule binding protein that stabilizes microtubules and induces G2/M arrest. Oncogene, 2004, 23(50):8216–8230PubMedCrossRefGoogle Scholar
  15. 15.
    Shivakumar L, Minna J, Sakamaki T, et al. The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation. Mol Cell Biol, 2002,22(12): 4309–4318PubMedCrossRefGoogle Scholar
  16. 16.
    Premzl A, Puizdar V, Zavasnik-Bergant V, et al. Invasion of ras-transformed breast epithelial cells depends on the proteolytic activity of cysteine and aspartic proteinases. Biol Chem, 2001,382:853–857PubMedCrossRefGoogle Scholar
  17. 17.
    Dhanesuan N, Sharp JA, Blick T, et al. Doxycycline-inducible expression of SPARC/Osteonectin/BM40 in MDA-MB-23 1 human breast cancer cells results in growth inhibition. Breast Cancer Res Treat, 2002(1),75(1): 73–85PubMedCrossRefGoogle Scholar
  18. 18.
    Agathanggelou A, Bieche I, Ahmed-Choudhury J, et al. Identification of novel gene expression targets for the Ras association domain family 1 (RASSF1A) tumor suppressor gene in non-small cell lung cancer and neuroblastoma. Cancer Res, 2003,63:5344–5351PubMedGoogle Scholar

Copyright information

© Huazhong University of Science and Technology and Springer Berlin Heidelberg 2009

Authors and Affiliations

  • Geqiong Xiao (肖葛琼)
    • 1
  • Tao Zhang (张 涛)
    • 1
  • Jie Yao (姚 杰)
    • 1
  • Jinghua Ren (任精华)
    • 1
  • Wenmiao Cao (曹文淼)
    • 1
  • Gang Wu (伍 钢)
    • 1
  1. 1.Cancer Center, Union Hospital, Tongji Medical CollegeHuazhong University of Sciences and TechnologyWuhanChina

Personalised recommendations